Publications by authors named "Jennifer Kwon"

Claim this Profile
I
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.
Jennifer M Kwon, Francina Munell, Laure Le Goff, Kotaro Yuge, Tamaki Kato

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations.
Crystal M Proud, Elizabeth A Kichula, Susan E Matesanz, Ashutosh Kumar, Kayoko Saito, Jennifer M Kwon

J Neuromuscul Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toddler With Recurrent Episodes of Loss of Consciousness.
Jesse M Boyett Anderson, Jennifer Kwon, Kathleen R Maginot

Pediatr Rev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case series.
Melissa D Svoboda, Nancy Kuntz, Carmen Leon-Astudillo, Barry J Byrne, Jena Krueger, Jennifer M Kwon

BMC Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S.
Sandra Smieszek, Bartlomiej Przychodzen, Christina Tyner, Caroline Johnson, Haimeng Bai, Jennifer M Kwon

Mol Ther Nucleic Acids· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and assessment of educational materials for spinal muscular atrophy carrier screening in the Plain community.
Carly Eichten, Ashley Kuhl, Mei Baker, Jennifer M Kwon, Christine M Seroogy

J Genet Couns· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herbal extracts in orofacial pain: a systematic review and direct and indirect meta-analysis.
Sara Delgadillo Barrera, Lilia Jadith Bernal Cepeda, David Augusto Díaz Báez, Jennifer Kwon, Abdelmonem Siddiq

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up Cares and Check Initiative: A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn Screening.
Mei Lietsch, Kee Chan, Jennifer Taylor, Bo Hoon Lee, Emma Ciafaloni, Jennifer M Kwon

Int J Neonatal Screen· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system.
Jounghyun H Lee, Kevin L Shores, Jason J Breithaupt, Caleb S Lee, Daniella M Fodera, Jennifer B Kwon

APL Bioeng· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Mortality Rates in Los Angeles County Among People Experiencing Homelessness, March 2020-February 2021.
Alicia H Chang, Jennifer J Kwon, Chelsea L Shover, Lisa Greenwell, Ayodele Gomih

Public Health Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Homeless Management Information System for COVID-19 Surveillance Among People Experiencing Homelessness.
Padma S Jones, Karen W Yeh, Hannah K Brosnan, Dalia Regos-Stewart, Cathy Ngo, Jennifer Kwon

J Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.
Kevin A Strauss, Michelle A Farrar, Francesco Muntoni, Kayoko Saito, Jerry R Mendell, Jennifer M Kwon

Nat Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial.
Kevin A Strauss, Michelle A Farrar, Francesco Muntoni, Kayoko Saito, Jerry R Mendell, Jennifer M Kwon

Nat Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy.
Jennifer M Kwon, Kapil Arya, Nancy Kuntz, Han C Phan, Cory Sieburg

Ann Clin Transl Neurol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune Encephalitis: Distinguishing Features and Specific Therapies.
Dominic O Co, Jennifer M Kwon

Crit Care Clin· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Professional identity formation: The key contributors and dental students' concerns.
Jennifer H Kwon, Charles F Shuler, HsingChi von Bergmann

J Dent Educ· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newborn screening for spinal muscular atrophy: The Wisconsin first year experience.
Mei W Baker, Sean T Mochal, Sandra J Dawe, Amy E Wiberley-Bradford, Michael F Cogley, Jennifer M Kwon

Neuromuscul Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy.
Elizabeth A Kichula, Crystal M Proud, Michelle A Farrar, Jennifer M Kwon, Kayoko Saito

Muscle Nerve· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.
John W Day, Richard S Finkel, Claudia A Chiriboga, Anne M Connolly, Thomas O Crawford, Jennifer M Kwon

Lancet Neurol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy.
Jennifer B Kwon, Adarsh R Ettyreddy, Ashish Vankara, Joel D Bohning, Garth Devlin

Mol Ther Methods Clin Dev· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myogenic Progenitor Cell Lineage Specification by CRISPR/Cas9-Based Transcriptional Activators.
Jennifer B Kwon, Ashish Vankara, Adarsh R Ettyreddy, Joel D Bohning, Charles A Gersbach

Stem Cell Reports· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience.
Aravindhan Veerapandiyan, Katy Eichinger, Debra Guntrum, Jennifer Kwon, Lindsay Baker

Muscle Nerve· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jumping at the chance for precise DNA integration.
Jennifer B Kwon, Charles A Gersbach

Nat Biotechnol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal Muscular Atrophy: Past, Present, and Future.
Lainie Friedman Ross, Jennifer M Kwon

Neoreviews· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the specificity of CRISPR systems with engineered RNA secondary structures.
D Dewran Kocak, Eric A Josephs, Vidit Bhandarkar, Shaunak S Adkar, Jennifer B Kwon

Nat Biotechnol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis